Read Time:36 Second
Abbott Laboratories said Tuesday it plans to restart manufacturing formula at its plant in Sturgis, Mich., on June 4, and it will prioritize production of EleCare, a hypoallergenic, amino acid-based formula. The company said that batch of Elecare formula is expected to be available to consumers around June 20. Abbott also said it is releasing some EleCare cans that were put on hold as a result of the Feb. 17 recall of Similac and Alimentum formulas. Abbott’s stock has slid 19.1% this year, while the broader S&P 500 is down 17.3%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
